CLINICAL_TRIALS
trial_result
· 2014-08-25
Clinical Trial Update: Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma [Phase 2]
Summary
Phase 2 trial of intralesional PV-10 for metastatic melanoma completed; results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Provectus Pharmaceuticals | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2014-08-25